Abstract

Neurons typically release both a small-molecule neurotransmitter and one or more neuropeptides, but how these two types of signal from the same neuron might act together remains largely obscure. For example, serotonergic neurons in mammalian brain express the neuropeptide Substance P, but it is unclear how this co-released neuropeptide might modulate serotonin signaling. We studied this issue in C. elegans, in which all serotonergic neurons express the neuropeptide NLP-3. The serotonergic Hermaphrodite Specific Neurons (HSNs) are command motor neurons within the egg-laying circuit which have been shown to release serotonin to initiate egg-laying behavior. We found that egg-laying defects in animals lacking serotonin were far milder than in animals lacking HSNs, suggesting that HSNs must release other signal(s) in addition to serotonin to stimulate egg laying. While null mutants for nlp-3 had only mild egg-laying defects, animals lacking both serotonin and NLP-3 had severe defects, similar to those of animals lacking HSNs. Optogenetic activation of HSNs induced egg laying in wild-type animals, and in mutant animals lacking either serotonin or NLP-3, but failed to induce egg laying in animals lacking both. We recorded calcium activity in the egg-laying muscles of animals lacking either serotonin, NLP-3, or both. The single mutants, and to a greater extent the double mutant, showed muscle activity that was uncoordinated and unable to expel eggs. Specifically, the vm2 muscles cells, which are direct postsynaptic targets of the HSN, failed to contract simultaneously with other egg-laying muscle cells. Our results show that the HSN neurons use serotonin and the neuropeptide NLP-3 as partially redundant co-transmitters that together stimulate and coordinate activity of the target cells onto which they are released.

Highlights

  • Drugs that selectively manipulate serotonin signaling are widely used to treat depression and other psychiatric disorders, yet these drugs are often ineffective, and no specific molecular defects in serotonin signaling have been identified as the cause of these disorders [1]

  • One feature of serotonin signaling in the mammalian brain that remains poorly understood is that serotonin neurons appear to release a specific neuropeptide, Substance P [2,3,4,5,6]

  • The serotonergic Hermaphrodite-Specific Neurons (HSNs), along with the cholinergic Ventral Cord type C neurons (VCs), synapse onto the type 2 vulval muscles, which contract with the type 1 vulval muscles to expel eggs [20]

Read more

Summary

Introduction

Drugs that selectively manipulate serotonin signaling are widely used to treat depression and other psychiatric disorders, yet these drugs are often ineffective, and no specific molecular defects in serotonin signaling have been identified as the cause of these disorders [1] This situation suggests there is more to understand about the basic science of serotonin signaling that could help explain the cause of psychiatric disorders. The apparent co-release of serotonin and Substance P from the same neurons is one instance of the broad but poorly studied phenomenon of co-transmission by small-molecule neurotransmitters and neuropeptides [11,12,13,14]. It remains unclear how exactly co-released serotonin and neuropeptide(s) might functionally interact. One study in the brain stem respiratory circuit indicated that serotonin and substance P each independently stimulate activity of the circuit [10], but the complexity of mammalian brain circuits makes precise analysis of such effects difficult

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call